BioTelemetry (BEAT) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results
November 5, 2019 4:06 PM ESTExceeds ExpectationsDelivers Double Digit Revenue Growth
MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2019.
Quarter Highlights Â
Recognized quarterly revenue of $111.3 millionReached 11.3% year-over-year revenue growthAchieved 29th consecutive quarter of year-over-year revenue growthReported GAAP net income of $8.3 millionRealized quarterly adjusted EBITDA of... More